SCHEMBL13702154

SCHEMBL13702154

CC(C)NC(=O)c1ccc(=O)n(CCO)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.45
BRD2 P25440 2/20 0.45
BRD3 Q15059 2/20 0.45
BRDT Q58F21 2/20 0.45
EPHX2 P34913 2/20 0.45
MAPT P10636 3/20 0.43
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
ALOX15 P16050 1/20 0.42
PTGS2 P35354 1/20 0.42
MLYCD O95822 1/20 0.42
HRH3 Q9Y5N1 3/20 0.39
KDM4E B2RXH2 2/20 0.39
GAA P10253 2/20 0.39
HPGD P15428 2/20 0.39
GLA P06280 1/20 0.39
HSD17B10 Q99714 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14007191 0.87 ALDH1A1 (0.49) BRD4BRD2BRD3BRDTEPHX2
SCHEMBL14007207 0.85 MLYCD (0.47) BRD4BRD2BRD3BRDTEPHX2
SCHEMBL13702178 0.85 HRH3 (0.51) BRD4BRD2BRD3BRDTEPHX2
SCHEMBL13702123 0.83 EPHX2 (0.64) BRD4BRD2BRD3BRDTEPHX2
SCHEMBL13702184 0.83 HRH3 (0.50) BRD4BRD2BRD3BRDTEPHX2
SCHEMBL14007194 0.82 BRD4 (0.55) BRD4BRD2BRD3BRDTEPHX2
SCHEMBL14007199 0.82 BRD4 (0.45) BRD4BRD2BRD3BRDTEPHX2
SCHEMBL14007204 0.81 HRH3 (0.58) ALDH1A1HRH3KDM4EGAAHPGD
SCHEMBL13702175 0.81 EPHX2 (0.45) BRD4BRD2BRD3BRDTEPHX2
SCHEMBL14007193 0.80 EPHX2 (0.52) BRD4BRD2BRD3BRDTEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors FLECK ROMAN WOLFGANG 2009-09-10 US disclosed
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors FLECK ROMAN WOLFGANG 2009-09-10 US disclosed
US-20080280904-A1 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors ELDRUP ANNE BETTINA 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280904-A1 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors EPHX1, EPHX2, DOHH BRD4 2988/4885BRD2 3385/4885BRD3 3422/4885
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors EPHX1, EPHX2, EPX BRD4 2517/4885BRD2 3424/4885BRD3 2358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.